CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teijin Limited v. Alembic Pharmaceuticals Limited

1:13-cv-01939

Overview

Case Number 1:13-cv-01939
Filing Date 2013-11-19
Status Terminated
Termination Date 2016-05-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Alembic Pharmaceuticals Limited NPE (University / Research)

Represented By

5 Attorneys Listed

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Yun Wei

Email: sophie.wei@pillsburylaw.com

Yuezhong Feng

Email: yfeng@brinksgilson.com

Ralph J. Gabric

Email: ralph.gabric@haynesboone.com

Manish K. Mehta

Email: mmehta@beneschlaw.com

Plaintiff

Takeda Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Zhiqiang Liu

Email: zliu@pbwt.com

Willam F Cavanaugh , Jr.

Email: wfcavanaugh@pbwt.com

Scott B. Howard

Email: sbhoward@pbwt.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Pharma Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jason T. Christiansen

Email: jasonchristiansen@paulhastings.com

James T. Evans

Email: jamesevans@paulhastings.com

David M. Conca

Email: davidconca@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 8 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (8 found):
U.S. Courts: 8
U.S. District Court 2015-06-04
1:15-cv-00454

Teijin Limited v. Macleods Pharmaceuticals Ltd.

U.S. Family Sibling (["US7361676"])
Status: DED
U.S. District Court 2014-11-04
1:14-cv-01370

Teijin Limited v. Unimark Remedies Ltd.

U.S. Family Sibling (["US7361676", "US8372872"])
Status: DED
U.S. District Court 2014-07-01
1:14-cv-00854

Teijin Limited v. Prinston Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-12
1:14-cv-00189

Teijin Limited v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-07
1:14-cv-00166

Teijin Limited v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-12-23
1:13-cv-02086

Teijin Limited v. Zydus Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-11-06
1:13-cv-01851

Teijin Limited v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-30
1:13-cv-01780

Teijin Limited v. Dr. Reddy's Laboratories Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6225474
Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
Filed: 1999-06-18
Issued: 2001-05-01
Expired (Term Ended)
Expires: 2019-06-18
US7361676
Solid preparation containing single crystal form
Filed: 2003-03-28
Issued: 2008-04-22
Expired (Term Ended) +346d PTA
Expires: 2024-03-08
US8372872
Methods for concomitant treatment of theophylline and febuxostat
Filed: 2011-11-14
Issued: 2013-02-12
Active (5.0 yrs remaining)
Expires: 2031-11-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1 Motion to Stay 1

Key Dispositive Motions & Rulings

Motion to Stay Pending / Under Review
STIPULATION to stay the case for a period of thirty (30) days to accommodate a possible amicable resolution by Alembic Pharmaceuticals Limited. (Farnan, Kelly) ...
Entry #80 • 2016-02-04 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re 23 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. ( Joinder of Parties due by 10/9/2015., Amended Plea...
Entry #— • 2014-03-28

Docket Entries

(152 total)
Pleading / Complaint

COMPLAINT filed against Alembic Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1410682.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 11/20/2013)

Entry #1 • 2013-11-19
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 11/20/2013)

Entry #2 • 2013-11-19
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about 10/7/2013. Date of Expiration of Patent: 06/18/2019.Thirty Month Stay Deadline: At the end of the day 8/16/2016. (dmp, ) (Entered: 11/20/2013)

Entry #3 • 2013-11-19
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,225,474 B1;. (dmp, ) (Entered: 11/20/2013)

Entry #4 • 2013-11-19
1

Disclosure Statement pursuant to Rule 7.1 filed by Teijin Limited, Teijin Pharma Limited identifying Corporate Parent Teijin Limited for Teijin Pharma Limited. (dmp, ) (Entered: 11/20/2013)

Entry #5 • 2013-11-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc